-transparent.png){kind=logo}
Moroccan Jewry (N>750,000) is the only non-Ashkenazi Jewish community in which Tay-Sachs disease (TSD) is not extremely rare. Previous studies among Moroccan Jewish TSD families identified three HEXA mutations. In this study, extended to enzyme-defined and new obilgate TSD carriers, we found four additional mutations. One of them is a novel, IVS5-2(A-->G) substitution, resulting in exon skipping, and it was found only among enzyme-defined carriers. The seven HEXA identified mutations among Moroccan Jews are: deltaF(304/305), R170Q, IVS-2(A-->G), Y180X, E482K, 1278+TATC, and IVS12+1(G-->C). Their respective distribution among 51 unrelated enzyme-defined and obligate carriers is 22:19:6:1:1:1:1. The mutation(s) remain unknown in only three enzyme-defined carriers. Five of the seven Moroccan mutations, including the three most common ones, were not found among Ashkenazi Jews. Compared with the much larger and relatively homogeneous Ashkenazi population, the finding among Moroccan Jews probably reflects their much longer history.
M Kaufman, and
J Grinshpun-Cohen, and
M Karpati, and
L Peleg, and
B Goldman, and
E Akstein, and
A Adam, and
R Navon
January 1983,
Israel journal of medical sciences,
M Kaufman, and
J Grinshpun-Cohen, and
M Karpati, and
L Peleg, and
B Goldman, and
E Akstein, and
A Adam, and
R Navon
January 1977,
Social biology,
M Kaufman, and
J Grinshpun-Cohen, and
M Karpati, and
L Peleg, and
B Goldman, and
E Akstein, and
A Adam, and
R Navon
August 2009,
Human genetics,
M Kaufman, and
J Grinshpun-Cohen, and
M Karpati, and
L Peleg, and
B Goldman, and
E Akstein, and
A Adam, and
R Navon
September 2021,
Klinische Padiatrie,
M Kaufman, and
J Grinshpun-Cohen, and
M Karpati, and
L Peleg, and
B Goldman, and
E Akstein, and
A Adam, and
R Navon
February 2010,
Biochemical and biophysical research communications,
M Kaufman, and
J Grinshpun-Cohen, and
M Karpati, and
L Peleg, and
B Goldman, and
E Akstein, and
A Adam, and
R Navon
May 2021,
Klinische Padiatrie,
M Kaufman, and
J Grinshpun-Cohen, and
M Karpati, and
L Peleg, and
B Goldman, and
E Akstein, and
A Adam, and
R Navon
November 1998,
Molecular genetics and metabolism,
M Kaufman, and
J Grinshpun-Cohen, and
M Karpati, and
L Peleg, and
B Goldman, and
E Akstein, and
A Adam, and
R Navon
January 2014,
Molecular genetics and metabolism reports,
M Kaufman, and
J Grinshpun-Cohen, and
M Karpati, and
L Peleg, and
B Goldman, and
E Akstein, and
A Adam, and
R Navon
February 1991,
American journal of human genetics,
M Kaufman, and
J Grinshpun-Cohen, and
M Karpati, and
L Peleg, and
B Goldman, and
E Akstein, and
A Adam, and
R Navon
February 2004,
Neurogenetics,
